Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bonaventure

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical developmentMichael A Letavic, Leah Aluisio, John R Atack, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.
Journal of Medicinal Chemistry|May 12, 2017
4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical CandidateMichael A Letavic, Brad M Savall, Brett D Allison, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Novel benzamide-based histamine h3 receptor antagonists: the identification of two candidates for clinical developmentMichael A Letavic, Leah Aluisio, Richard Apodaca, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical developmentMichael A Letavic, Leah Aluisio, John R Atack, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.
Journal of Medicinal Chemistry|May 12, 2017
4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical CandidateMichael A Letavic, Brad M Savall, Brett D Allison, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Novel benzamide-based histamine h3 receptor antagonists: the identification of two candidates for clinical developmentMichael A Letavic, Leah Aluisio, Richard Apodaca, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 10